Navigation Links
Urine Test Might Help Predict Prostate Cancer Risk
Date:8/3/2011

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, Aug. 3 (HealthDay News) -- A new urine test might help doctors detect prostate cancer and better evaluate a patient's treatment options, researchers say.

"This is a tool that men and their physician can use to help them decide whether it's appropriate to get a biopsy now or delay that decision," said lead researcher Dr. Scott Tomlins, a pathology resident at the University of Michigan Health System.

The test looks for two genetic markers associated with prostate cancer. The first, called TMPRSS2:ERG, is caused by two genes changing places and fusing together; it is thought to cause prostate cancer. Since the gene fusion is only seen in about half of cancer patients, the test also looks for another marker, called PCA3.

"We are exploiting some new bio-markers to try to refine the PSA [prostate-specific antigen] test," Tomlins said.

The PSA test can indicate prostate cancer, but it is unreliable, often producing false positives and false negatives, Tomlins said. "You can have low PSA and have cancer, or high PSA and not have cancer," he said.

The two genetic markers may be more reliable indicators of prostate cancer, he said. One of them, TMPRSS2:ERG, is only seen in cancer, he added.

Together, they can be used "to stratify men into saying, 'You have a high chance of having cancer, and you should get a biopsy now, or if you are in a lower risk group you have a much lower risk of cancer and perhaps you could delay the biopsy,'" Tomlins said.

However, Tomlins cautioned that the test is not perfect. "It's hard to recommend that someone not get a biopsy, because there is always a chance you are going to miss a cancer that doesn't have either of these two markers," he said.

For the study, published in the Aug. 3 issue of Science Translational Medicine, Tomlins' team studied urine samples from 1,312 men who had high PSA levels and had had a prostate biopsy or surgery to remove the prostate.

The researchers specifically looked for the two markers and used them to slot the men into high-, intermediate- or low-risk groups for prostate cancer. They then compared their results with the results from biopsies, which are done with a needle in a physician's office for detection of any cancer cells.

Based on the biopsies, cancer was found in 21 percent of the men in the low-risk group, in 43 percent of the intermediate-risk group and in 69 percent of the high-risk group.

The researchers said the findings of the urine tests correlated with tumor size and the cancer's aggressiveness. In the low-risk group, only 7 percent had aggressive cancer, compared with 40 percent of the men classified as high-risk, they found.

One limitation of the study is that most patients were Caucasian, so further studies are needed to see whether the findings extend to all men, the researchers noted.

Although not yet available to the public, the test soon will be offered at the University of Michigan, Tomlins said.

The test is licensed to Gen-Probe, a San Diego maker of genetically based diagnostic tests. Mike Watt, a company spokesman, said the test is still in the early stages of development and has not been submitted to the U.S. Food and Drug Administration for approval. The company has no firm idea of the test's cost should it be approved, Watt added.

Study funding was supported in part by Gen Probe, and the University of Michigan and Brigham and Womens Hospital have obtained a patent on the detection of ETS gene fusion in prostate cancer, in which four co-authors are listed as co-inventors.

A prostate cancer expert, Dr. Anthony D'Amico, chief of radiation oncology at Brigham and Women's Hospital in Boston, said the test is "a step forward, but we still have a ways to go."

"On average the risk is higher in people with both markers and lowest in people who have neither, but that's on average," D'Amico said.

If a patient has indications of an aggressive prostate cancer, the test can add more to that diagnosis, D'Amico said. But for men who potentially have cancer, a low-risk determination based on this test shouldn't preclude biopsy, he said.

"It adds fuel to the fire when you suspect something bad, but I don't think it takes you out of the woods when these markers are not present," D'Amico said.

More information

For more information on prostate cancer, visit the American Cancer Society.

SOURCES: Scott Tomlins, M.D., Ph.D., pathology resident, University of Michigan Health System, Ann Arbor; Anthony D'Amico, M.D., Ph.D., chief, radiation oncology, Brigham and Women's Hospital, Boston; Mike Watt, spokesman, Gen-Probe, San Diego, Calif.; Aug. 3, 2011, Science Translational Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
2. Urine test for kidney cancer a step closer to development
3. Moving Closer to a Urine Test for Colon Cancer
4. Autism finding could lead to simple urine test for the condition
5. Color, Odor Changes in Urine Usually -- But Not Always -- Harmless, Reports Harvard Women's Health Watch
6. Urine Markers May Reveal Kidney Damage Earlier
7. Protein in the urine: A warning sign for cognitive decline
8. Urine-sniffing dogs: Early detection of prostate cancer
9. Home urine test measures insulin production in diabetes
10. First measurements of HAAs in urine of swimmers and pool workers
11. An advance toward an electronic nose urine test for TB
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Urine Test Might Help Predict Prostate Cancer Risk 
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
Breaking Medicine Technology: